Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection

DNA 叉保护揭示细胞和分子肿瘤抑制过程

基本信息

项目摘要

DESCRIPTION (provided by applicant): The applicant, Katharina Schlacher, is committed to a lifelong academic career and aims to become an independent investigator and enabling mentor at the frontier of cancer research in the field of replication fork protection. Katharina proposes three-year plan that will optimally equip her to becoming a successful independent research investigator in this challenging funding environment. The proposed project seeks to study cellular and molecular processes of replication fork protection by tumor-suppressor. The specific aims of the project are as follows: Aim1 Investigating replication fork instability in tumor cells, Aim2 Testing FA-media ed replisome stability, and Aim3 Determining RAD51 paralog tumor suppressor functions during fork protection. The proposed Aims will obtain critical knowledge on the impact of this new area of research to tumor biology, to understand its role in tumor cells and to initiate detailed insights into fork protection. This project will strengthen her abilities nd this new research area that is at the heart of her independent career, during which she aspires to decipher the mechanism of replication fork protection, identify new players of this pathway and open doors to understanding its implications with regards to stem cell biology and therapeutic strategies Under the mentorship of Dr. Maria Jasin (MSKCC) and co-mentor Dr. Hong Wu (UCLA), the candidate will meet regularly with her mentors, interact with other pertinent experts in the field, and supplement her training with structured meetings, conferences, and coursework. The award will produce sufficient preliminary data for independent funding applications, and enable her to acquire key technical knowledge, experience, and data needed to build and substantiate this new research area, to successfully jump-start her independent career and to secure an independent faculty position in health-related research. She will gain key extra and complementary experience in IPOND, Rad51 paralogs, and Talen technology for genomic engineering as well as on replication fork instability in mammary, ovarian and pancreatic tumor cells. Dr. Schlacher and her mentors thus view this project as a critical enabling opportunity for her to meet the challenges of her research goals and aspirations.
申请人Katharina Schlacher致力于终身学术生涯,旨在成为复制叉保护领域癌症研究前沿的独立研究者和导师。卡塔琳娜提出了三年计划,这将使她在这个充满挑战的资金环境中成为一名成功的独立研究调查员。该项目旨在研究肿瘤抑制因子保护复制叉的细胞和分子过程。该项目的具体目标如下:目的1研究肿瘤细胞中复制叉的不稳定性,目的2测试FA-培养基艾德复制体的稳定性,目的3确定RAD 51在叉保护期间的副肿瘤抑制因子功能。拟议的目标将获得关于这一新的研究领域对肿瘤生物学的影响的关键知识,了解其在肿瘤细胞中的作用,并启动对叉保护的详细见解。这个项目将加强她的能力和这个新的研究领域,这是她独立职业生涯的核心,在此期间,她渴望破译复制叉保护的机制,确定这一途径的新参与者,并打开大门,了解其对干细胞生物学和治疗策略的影响。候选人将定期与导师会面,与该领域的其他相关专家互动,并通过结构化会议,会议和课程来补充她的培训。该奖项将产生足够的初步数据为独立的资金申请,并使她能够获得关键的技术知识,经验和数据需要建立和充实这个新的研究领域,成功地启动她的独立职业生涯,并确保独立的教师职位在健康相关的研究。她将在IPOND,Rad 51旁系同源物和Talen基因组工程技术以及乳腺,卵巢和胰腺肿瘤细胞中的复制叉不稳定性方面获得关键的额外和补充经验。Schlacher博士和她的导师因此认为这个项目是一个关键的机会,使她能够满足她的研究目标和愿望的挑战。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katharina Schlacher其他文献

Katharina Schlacher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Katharina Schlacher', 18)}}的其他基金

Mechanism of RAD51C fork protection and environmental carcinogenesis
RAD51C叉保护与环境致癌机制
  • 批准号:
    10192722
  • 财政年份:
    2018
  • 资助金额:
    $ 13.95万
  • 项目类别:
Mechanism of RAD51C fork protection and environmental carcinogenesis
RAD51C叉保护与环境致癌机制
  • 批准号:
    10406253
  • 财政年份:
    2018
  • 资助金额:
    $ 13.95万
  • 项目类别:
Mechanism of RAD51C fork protection and environmental carcinogenesis
RAD51C叉保护与环境致癌机制
  • 批准号:
    9925229
  • 财政年份:
    2018
  • 资助金额:
    $ 13.95万
  • 项目类别:
Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection
DNA 叉保护揭示细胞和分子肿瘤抑制过程
  • 批准号:
    8488140
  • 财政年份:
    2013
  • 资助金额:
    $ 13.95万
  • 项目类别:
Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection
DNA 叉保护揭示细胞和分子肿瘤抑制过程
  • 批准号:
    8827169
  • 财政年份:
    2013
  • 资助金额:
    $ 13.95万
  • 项目类别:
Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection
DNA 叉保护揭示细胞和分子肿瘤抑制过程
  • 批准号:
    8635320
  • 财政年份:
    2013
  • 资助金额:
    $ 13.95万
  • 项目类别:

相似海外基金

Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 13.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
  • 批准号:
    10722602
  • 财政年份:
    2022
  • 资助金额:
    $ 13.95万
  • 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
  • 批准号:
    10368246
  • 财政年份:
    2022
  • 资助金额:
    $ 13.95万
  • 项目类别:
Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells
Eltombopag:对正常和再生障碍性贫血造血干细胞的新作用模式
  • 批准号:
    10676888
  • 财政年份:
    2022
  • 资助金额:
    $ 13.95万
  • 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
  • 批准号:
    10600143
  • 财政年份:
    2022
  • 资助金额:
    $ 13.95万
  • 项目类别:
The effects of somatic HLA class I allele mutations on antigen presentation in acquired aplastic anemia
体细胞 HLA I 类等位基因突变对获得性再生障碍性贫血抗原呈递的影响
  • 批准号:
    10347646
  • 财政年份:
    2022
  • 资助金额:
    $ 13.95万
  • 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
  • 批准号:
    10370775
  • 财政年份:
    2022
  • 资助金额:
    $ 13.95万
  • 项目类别:
The effects of somatic HLA class I allele mutations on antigen presentation in acquired aplastic anemia
体细胞 HLA I 类等位基因突变对获得性再生障碍性贫血抗原呈递的影响
  • 批准号:
    10545024
  • 财政年份:
    2022
  • 资助金额:
    $ 13.95万
  • 项目类别:
Identification of autoantigens presented by specific HLA class I alleles in aplastic anemia
再生障碍性贫血中特定 HLA I 类等位基因呈现的自身抗原的鉴定
  • 批准号:
    19H03686
  • 财政年份:
    2019
  • 资助金额:
    $ 13.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of novel genes related to aplastic anemia using mouse models.
使用小鼠模型对与再生障碍性贫血相关的新基因进行功能分析。
  • 批准号:
    19K08297
  • 财政年份:
    2019
  • 资助金额:
    $ 13.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了